Clinical Trials Logo

Clinical Trial Summary

This is a 3-week open label, one group study to determine the agreement between the pharmacological treatment recommended by TDApp1 and the interventions recommended by relevant clinical practice guidelines.


Clinical Trial Description

Clinical practice guidelines (CPGP) allow optimizing medical decisions and health care based on the best evidence available. Nevertheless, CPGs have several limitations. First, many GPC are outdated shortly after their publication. Second, CPG recommendations are often not applicable to many patients treated in clinical practice. Most CPGs do not make recommendations for patients with a mild disorder or for complex patients with comorbiditie. Another limitation is that patients involvement in CPGs development is still poor. We aim to develop and assess TDApp1: an eHealth tool to formulate participatory, individualized and automated therapeutic recommendations for patients with Attention Deficit Hyperactivity Disorder. A 3-week, one group, open label study will be conducted. Fifty-five patients aged 6-65 with ADHD will use TDApp1. The therapeutic recommendations made by the TDApp1 and by relevant CPG will be compared. Concordance in the recommendations will be studied. Effectiveness, safety, changes in physical activity and satisfaction will be investigated. ;


Study Design


Related Conditions & MeSH terms

  • Attention Deficit Disorder with Hyperactivity
  • Attention Deficit-hyperactivity Disorder
  • Hyperkinesis

NCT number NCT04228094
Study type Observational
Source Universitat de Girona
Contact
Status Completed
Phase
Start date August 10, 2020
Completion date May 9, 2022

See also
  Status Clinical Trial Phase
Completed NCT04152629 - Real World Evidence of the Efficacy and Safety of FOQUEST Phase 4
Completed NCT03003286 - Community Based Intervention for Children With ADHD and ASD N/A
Recruiting NCT04038073 - TLR Polymorphism, ASO and Beta-hemolytic Group A Streptococcus Infections in ADHD: an Observational Study
Completed NCT01831622 - Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder Phase 4
Completed NCT03847402 - The Early Integrated Intervention for Child Brain-developmental Disorders in China N/A
Withdrawn NCT01769300 - Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder N/A
Completed NCT03440346 - Biomarker Research in ADHD: the Impact of Nutrition N/A
Completed NCT04689282 - Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders Phase 1/Phase 2
Recruiting NCT02778360 - Effectiveness of a Personalized Neurofeedback Training Device (ADHD@Home) in Attention-Deficit/Hyperactivity Disorder Phase 1/Phase 2